Ticker,Title,Link
SNDX,"Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), OmniAb (OABI) and Syndax Pharmaceuticals (SNDX)",8/16/2024 10:41:10 AM
SNDX,Buy Rating Affirmed for Syndax Pharmaceuticals Amid Niktimvo’s Promising Market Entry and Efficacy,8/15/2024 1:25:15 PM
SNDX,Barclays Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX),8/5/2024 7:44:29 AM
SNDX,Syndax Pharmaceuticals: A Strong Buy on Robust Q2 Performance and Promising Market Strategy,8/4/2024 2:19:54 PM
SNDX,Stifel Nicolaus Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX),8/2/2024 12:51:31 PM
SNDX,Syndax Pharmaceuticals GAAP EPS of -$0.80 beats by $0.11,8/1/2024 8:38:05 PM
SNDX,3 Biotech Stocks That Could Make Your Summer Unforgettable,7/30/2024 7:07:52 PM
SNDX,Syndax drops as FDA extends target date for leukemia drug application,7/29/2024 2:41:19 PM
SNDX,Stifel Nicolaus Reaffirms Their Buy Rating on Syndax Pharmaceuticals (SNDX),7/25/2024 11:27:39 AM
SNDX,TD Cowen Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX),6/20/2024 10:25:57 AM
SNDX,Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Syndax Pharmaceuticals (SNDX),6/17/2024 2:40:27 PM
SNDX,"Analysts Are Bullish on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Protagonist Therapeutics (PTGX)",6/16/2024 12:30:31 PM
SNDX,Syndax Reports Updated Positive Data From Phase 1/2 Combination Trials Of Revumenib ,6/14/2024 1:22:31 PM
SNDX,Bank of America Securities Keeps Their Buy Rating on Syndax Pharmaceuticals (SNDX),6/13/2024 1:25:25 PM
SNDX,Barclays Remains a Buy on Syndax Pharmaceuticals (SNDX),6/7/2024 12:17:04 PM
SNDX,Buy Rating Affirmed for Syndax Pharmaceuticals on Clinical Progress and Regulatory Advancements,6/6/2024 1:35:23 PM
SNDX,"Analysts Are Bullish on Top Healthcare Stocks: Teva Pharmaceutical (TEVA), Cencora (COR)",5/23/2024 7:50:39 AM
SNDX,Syndax Pharmaceuticals: A Strong Buy on Commercial Opportunity and Near-Term Catalysts,5/17/2024 9:17:58 AM
SNDX,Syndax Pharmaceuticals (SNDX) Gets a Buy from Stifel Nicolaus,5/13/2024 2:07:43 AM
SNDX,"Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Syndax Pharmaceuticals (SNDX) and Tarsus Pharmaceuticals (TARS)",5/9/2024 11:31:05 AM
SNDX,SNDX Stock Earnings: Syndax Pharmaceuticals Beats EPS for Q1 2024,5/8/2024 3:53:53 PM
SNDX,Syndax Pharmaceuticals Q1 2024 Earnings Preview,5/7/2024 6:09:48 PM
SNDX,Buy Rating Reaffirmed for Syndax Pharmaceuticals on Strong Drug Pipeline and Strategic Partnerships,4/26/2024 10:15:37 AM
SNDX,"Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Inozyme Pharma (INZY) and PTC Therapeutics (PTCT)",4/9/2024 9:40:34 AM
SNDX,"Analysts Are Bullish on Top Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Legend Biotech (LEGN)",4/8/2024 11:50:05 PM
SNDX,"Crinetics,  Syndax gain amid pitch at Sohn charity conference (update)",4/3/2024 4:56:09 PM
SNDX,Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Quanterix (QTRX),3/27/2024 11:00:21 AM
SNDX,"FDA grants priority review for Syndax leukemia drug, sets action date",3/26/2024 9:11:27 PM
SNDX,Cantor sees strong year ahead for oncology M&A,3/10/2024 5:08:00 PM
SNDX,Buy Rating for Syndax Pharmaceuticals Amidst Strategic Progress and Regulatory Milestones,3/6/2024 12:45:54 AM
SNDX,Scotiabank Keeps Their Hold Rating on Syndax Pharmaceuticals (SNDX),2/28/2024 12:17:38 PM
SNDX,Syndax Pharmaceuticals files for a mixed securities shelf,2/27/2024 10:52:16 PM
SNDX,Notable earnings after Tuesday's close,2/26/2024 10:35:53 PM
SNDX,Barclays Releases a Buy Rating on Syndax Pharmaceuticals (SNDX),2/21/2024 11:51:37 AM
SNDX,Investors growing more bullish on SMID cap biotech stocks,2/4/2024 10:16:46 PM
SNDX,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX) and Pfizer (PFE),1/31/2024 12:20:52 PM
SNDX,"Analysts Are Bullish on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Pfizer (PFE)",1/30/2024 10:01:15 PM
SNDX,Strong Buy Rating for Syndax Pharmaceuticals Amidst Market Opportunities and Regulatory Milestones,1/26/2024 5:47:11 AM
SNDX,"Analysts’ Top Healthcare Picks: Athira Pharma (ATHA), Syndax Pharmaceuticals (SNDX)",1/5/2024 5:50:27 AM
SNDX,Wall Street Analysts Are Bullish on Top Healthcare Picks,1/4/2024 2:10:15 AM
SNDX,Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference,1/2/2024 10:05:00 PM
SNDX,BTIG Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX),12/31/2023 10:23:58 AM
SNDX,Syndax Pharmaceuticals: A Strong Buy on Robust Financial Position and Promising Drug Pipeline,12/22/2023 5:05:23 PM
SNDX,Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares,12/19/2023 10:16:00 PM
SNDX,Syndax Prices Public Offering Of About 10.8 Mln Shares At $18.50/share ,12/15/2023 8:23:06 AM
SNDX,Syndax Announces Proposed $150 Million Public Offering of Common Stock,12/14/2023 10:00:00 PM
SNDX,"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Ligand Pharma (LGND) and Syndax Pharmaceuticals (SNDX)",12/13/2023 12:20:55 PM
SNDX,Syndax Presents Positive Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at Late-Breaking Oral Presentation During 65th ASH Annual Meeting,12/12/2023 6:00:00 PM
SNDX,What's Going On With Leukemia-Focused Syndax Pharmaceuticals Stock Today?,12/11/2023 7:47:28 PM
SNDX,Syndax to Host Investor Event to Discuss Axatilimab and Revumenib Data Updates at 65th ASH Annual Meeting,12/4/2023 1:00:00 PM
SNDX,Syndax Announces Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia Selected as Late-Breaking Presentation at the 65th ASH Annual Meeting,11/21/2023 3:00:00 PM
SNDX,Syndax Announces Participation at Stifel Healthcare Conference,11/7/2023 1:00:00 PM
SNDX,Promising Clinical Trials and Strong Financial Health Drive Buy Rating for Syndax Pharmaceuticals,11/6/2023 6:23:59 AM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),11/3/2023 9:05:00 PM
SNDX,Syndax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update,11/2/2023 9:05:00 PM
SNDX,Stifel Nicolaus Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX),10/30/2023 2:06:19 AM
SNDX,Bank of America Says Contrarian Buy Signal Could Push Stocks Higher; Here Are 2 Names the Banking Giant Likes Right Now,10/27/2023 3:51:57 PM
SNDX,"Syndax to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 2, 2023",10/26/2023 1:00:00 PM
SNDX,Syndax Pharmaceuticals: A Promising Investment Based on Strong Drug Development Pipeline and Future Revenue Generation Prospects,10/24/2023 2:56:32 PM
SNDX,Analyst Ratings for Syndax Pharmaceuticals,10/17/2023 6:00:26 PM
SNDX,"Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023",10/11/2023 5:00:37 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),10/6/2023 10:05:00 PM
SNDX,Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Teladoc (TDOC),10/3/2023 11:20:47 AM
SNDX,What's Going On With Syndax Pharmaceuticals Stock Monday?,10/2/2023 5:51:16 PM
SNDX,"Syndax to Announce Topline Results from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia and Host an Investor Call on October 2, 2023",9/29/2023 10:05:00 PM
SNDX,"Analysts’ Top Healthcare Picks: Genmab (GMAB), Syndax Pharmaceuticals (SNDX)",9/5/2023 2:50:11 AM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),9/1/2023 10:05:00 PM
SNDX,Syndax Announces Participation at the Citi 18th Annual BioPharma Conference,8/31/2023 10:05:00 PM
SNDX,Syndax Pharmaceuticals (SNDX) Receives a Buy from BTIG,8/28/2023 1:35:14 PM
SNDX,"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Regeneron (REGN) and Syndax Pharmaceuticals (SNDX)",8/22/2023 10:11:27 AM
SNDX,"BofA starts Kura at buy, cites revenue potential of lead drug ziftomenib",8/11/2023 6:55:42 PM
SNDX,Syndax Pharmaceuticals (SNDX) Gets a Buy from Robert W. Baird,8/8/2023 9:15:44 AM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),8/4/2023 10:05:00 PM
SNDX,Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update,8/3/2023 10:05:00 PM
SNDX,"Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023",7/27/2023 5:00:41 PM
SNDX,Citigroup Maintains Buy Rating for Syndax Pharmaceuticals: Here's What You Need To Know,7/26/2023 7:00:27 PM
SNDX,What 7 Analyst Ratings Have To Say About Syndax Pharmaceuticals,7/25/2023 4:00:49 PM
SNDX,"Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End",7/24/2023 5:10:31 PM
SNDX,Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape,7/11/2023 9:43:05 PM
SNDX,Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Syndax Pharmaceuticals (SNDX),7/10/2023 8:20:06 AM
SNDX,"Acumen, BridgeBio, Arcus among BTIG's top healthcare picks for 2H 2023",7/9/2023 10:15:18 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),7/7/2023 10:13:00 PM
SNDX,Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Accolade (ACCD),6/30/2023 10:40:31 AM
SNDX,"3 Best Stocks to Buy Now, 6/26/2023, According to Top Analysts",6/26/2023 11:12:34 AM
SNDX,"Barclays bullish on Biomea, Replimune, Syndax, Iovance for 2H 2023",6/24/2023 1:00:44 AM
SNDX,Goldman Sachs Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX),6/12/2023 1:55:05 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),6/2/2023 10:05:00 PM
SNDX,Goldman Sachs Remains a Buy on Syndax Pharmaceuticals (SNDX),5/31/2023 8:25:15 PM
SNDX,Syndax Announces Participation at Two Upcoming Investor Conferences,5/24/2023 1:00:00 PM
SNDX,Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Premier (PINC),5/23/2023 12:20:06 PM
SNDX,Goldman Sachs Remains a Buy on Syndax Pharmaceuticals (SNDX),5/18/2023 4:15:18 AM
SNDX,Syndax Pharmaceuticals (SNDX) Receives a Buy from Goldman Sachs,5/12/2023 12:15:06 AM
SNDX,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Catalent (CTLT) and Syndax Pharmaceuticals (SNDX)",5/11/2023 4:06:30 PM
SNDX,Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update,5/8/2023 10:05:00 PM
SNDX,Syndax Pharmaceuticals Q1 2023 Earnings Preview,5/7/2023 9:35:00 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),5/4/2023 10:05:00 PM
SNDX,"Syndax to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 8, 2023",5/1/2023 1:00:00 PM
SNDX,Goldman Sachs Remains a Buy on Syndax Pharmaceuticals (SNDX),4/27/2023 12:15:10 AM
SNDX,Goldman Sachs Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX),4/19/2023 2:35:10 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),4/13/2023 10:05:00 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),4/7/2023 10:05:00 PM
SNDX,"Analysts Offer Insights on Healthcare Companies: Emergent Biosolutions (EBS), Syndax Pharmaceuticals (SNDX) and Mersana Therapeutics (MRSN)",3/31/2023 12:10:58 PM
SNDX,"Syndax Pharmaceuticals Announces Appointment of Neil Gallagher, M.D., Ph.D. as President, Head of Research and Development",3/30/2023 1:00:00 PM
SNDX,Syndax Pharmaceuticals Announces Two Publications in Nature of Data from the Phase 1 Portion of AUGMENT-101 in Acute Leukemia Patients,3/15/2023 9:05:00 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),3/6/2023 10:05:00 PM
SNDX,Robert W. Baird Reaffirms Their Buy Rating on Syndax Pharmaceuticals (SNDX),3/3/2023 5:25:26 AM
SNDX,Expert Ratings for Syndax Pharmaceuticals,3/1/2023 1:01:39 PM
SNDX,Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update,2/28/2023 10:03:00 PM
SNDX,Syndax Pharmaceuticals Q4 2022 Earnings Preview,2/27/2023 10:35:52 PM
SNDX,"Syndax to Announce Fourth Quarter and Year-end 2022 Financial Results and Host Conference Call and Webcast on February 28, 2023",2/21/2023 1:00:00 PM
SNDX,Syndax Announces Participation at Upcoming Investor Conferences,2/14/2023 1:00:00 PM
SNDX,"Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023",1/31/2023 4:00:32 PM
SNDX,J.P. Morgan Says These 2 Stocks Are Ready to Rip Higher — This Is What Makes Them Attractive Buys,1/6/2023 12:58:00 PM
SNDX,Syndax Announces Presentation at 41st Annual J.P. Morgan Healthcare Conference,1/4/2023 1:00:00 PM
SNDX,Syndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,12/14/2022 10:05:00 PM
SNDX,"Kura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidates",12/12/2022 6:34:01 PM
SNDX,Syndax Announces Positive Updated Data from Phase 1 Portion of AUGMENT-101 Trial of Revumenib in Patients with Acute Leukemias During Oral Presentations at 64th ASH Annual Meeting,12/10/2022 11:00:00 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),12/8/2022 11:06:00 PM
SNDX,"United Natural Foods, Ollie's Bargain, Smith & Wesson Brands And Some Other Big Stocks Moving Lower On Wednesday",12/7/2022 5:25:24 PM
SNDX,Syndax Announces Proposed $150 million Public Offering of Common Stock,12/6/2022 10:30:00 PM
SNDX,H.C. Wainwright Remains a Buy on Syndax Pharmaceuticals (SNDX),12/5/2022 4:15:15 PM
SNDX,"Syndax Pharma Names Steve Sabus Chief Commercial Officer, Effective Dec. 5 ",12/2/2022 2:10:54 PM
SNDX,Syndax Announces Participation at Evercore ISI Annual HealthCONx Conference,11/21/2022 1:00:00 PM
SNDX,"Analysts Are Bullish on Top Healthcare Stocks: Matinas BioPharma (MTNB), Syndax Pharmaceuticals (SNDX)",11/4/2022 2:10:57 PM
SNDX,Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update,11/3/2022 9:05:00 PM
SNDX,Syndax Pharmaceuticals earnings preview: what to expect,11/2/2022 3:01:13 PM
SNDX,"Syndax to Announce Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 3, 2022",10/27/2022 1:00:00 PM
SNDX,"These Biotech Stocks Hit New 52-week High, Were They In Your Portfolio? ",10/7/2022 4:06:00 PM
SNDX,Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update,8/8/2022 10:05:00 PM
SNDX,Notable earnings after Monday's close,8/7/2022 9:35:38 PM
SNDX,"Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022",8/2/2022 1:00:00 PM
SNDX,Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),6/16/2022 10:30:00 PM
SNDX,Syndax Pharmaceuticals Appoints Keith Goldan As CFO ,6/13/2022 2:39:36 PM
SNDX,Syndax Announces Participation at Two Upcoming Investor Conferences,5/26/2022 1:00:00 PM
SNDX,Syndax Announces Participation at Citi's Biopharma Virtual Co-Panel Day,5/11/2022 1:00:00 PM
SNDX,Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update,5/9/2022 10:05:00 PM
SNDX,Notable earnings after Monday's close,5/8/2022 9:35:08 PM
SNDX,"Syndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022",5/2/2022 1:00:00 PM
SNDX,"LAZR, VECO and EVCM among after hour movers",4/18/2022 9:40:37 PM
SNDX,"Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022",4/11/2022 4:07:09 PM
SNDX,Do Penny Stocks Ever Make Money? Here Are 7 Success Stories,4/10/2022 11:30:36 AM
SNDX,Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),3/4/2022 10:05:00 PM
SNDX,Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update,3/1/2022 10:05:00 PM
SNDX,Notable earnings after Tuesday's close,2/28/2022 10:35:45 PM
SNDX,"Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2022",2/15/2022 4:02:49 PM
SNDX,Soligenix to Present at the 2022 BIO CEO & Investor Conference,2/8/2022 1:30:00 PM
SNDX,"The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures",2/4/2022 1:34:06 PM
SNDX,"Syndax Pharmaceuticals Announces Transition of Michael A. Metzger to Chief Executive Officer; Briggs W. Morrison, M.D., to Assume Role of President, Head of Research & Development",2/3/2022 10:01:00 PM
SNDX,Notable earnings after Thursday's close,2/2/2022 10:35:53 PM
SNDX,Syndax Announces Presentation at B. Riley Securities' 2022 Oncology Conference,1/20/2022 1:00:00 PM
SNDX,Syndax Announces Presentation at 40th Annual J.P. Morgan Healthcare Conference,1/7/2022 1:00:00 PM
SNDX,EU Grants Orphan Drug Designation To Syndax's SNDX-5613 For Acute Myeloid Leukemia Treatment ,12/22/2021 1:11:35 PM
SNDX,Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares,12/20/2021 10:05:00 PM
SNDX,Syndax Pharma raises $75M via stock offering,12/16/2021 5:45:35 AM
SNDX,Syndax Announces Proposed Public Offering of Common Stock,12/15/2021 10:29:00 PM
SNDX,"Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial",12/14/2021 12:22:06 PM
SNDX,Syndax Pharmaceuticals Announces Additional Positive Data Demonstrating Continued Robust Clinical Activity with Durable Responses in Phase 1 Portion of AUGMENT-101 Trial of SNDX-5613,12/13/2021 8:45:00 PM
SNDX,Syndax Pharmaceuticals Announces Updated Positive Data Demonstrating Broad Activity and Tolerability of Axatilimab in Patients with Chronic Graft-Versus-Host Disease,12/11/2021 8:00:00 PM
SNDX,Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab,12/9/2021 10:05:00 PM
SNDX,Syndax Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Business Update,11/15/2021 10:05:00 PM
SNDX,Notable earnings after Monday's close,11/14/2021 10:35:00 PM
SNDX,Syndax Pharmaceuticals Inc hosts conference call for investors,11/11/2021 2:45:00 PM
SNDX,"Syndax to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 15, 2021",11/8/2021 1:00:00 PM
SNDX,81 Biggest Movers From Yesterday,11/5/2021 10:01:49 AM
SNDX,Syndax Pharma falls after updating early-stage data for leukemia therapy,11/4/2021 7:20:31 PM
SNDX,"Aditxt, Synaptogenix leads healthcare gainers; UpHealth, Unity Biotechnology among major losers",10/5/2021 3:02:32 PM
SNDX,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",9/28/2021 2:18:52 PM
SNDX,"Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate",9/27/2021 3:23:12 PM
SNDX,"Syndax Appoints Martin H. Huber, M.D., to its Board of Directors",9/15/2021 10:01:00 PM
SNDX,Syndax Announces Participation at Three Upcoming Investor Conferences,9/2/2021 1:00:00 PM
SNDX,Syndax Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Business Update,8/9/2021 10:01:00 PM
SNDX,"The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight",8/8/2021 4:11:24 PM
SNDX,"Syndax to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021",8/2/2021 1:00:00 PM
SNDX,44 Stocks Moving In Monday's Mid-Day Session,6/28/2021 6:03:29 PM
SNDX,"Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021",5/25/2021 4:02:44 PM
SNDX,Syndax Pharma Updates On Interim Phase 1 Data From SNDX-5613 Leukemia Trial,5/12/2021 1:51:02 PM
SNDX,"NERV, UPST, ARRY and IOVA among after-hours movers",5/11/2021 9:43:33 PM
SNDX,"The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings",5/9/2021 4:20:33 PM
SNDX,"Last Week's Notable Insider Buys: AppLovin, Bed Bath And Beyond, TuSimple And More",4/25/2021 2:30:15 PM
SNDX,46 Biggest Movers From Yesterday,4/21/2021 11:12:27 AM
SNDX,Mid-Afternoon Market Update: Dow Tumbles 370 Points; Kansas City Southern Shares Spike Higher,4/20/2021 8:40:21 PM
SNDX,"The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs",4/17/2021 3:25:15 PM
SNDX,Seeking Alpha Catalyst Watch,4/16/2021 7:30:09 PM
SNDX,"The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs",4/9/2021 1:26:03 PM
SNDX,Syndax wins FDA’s orphan drug designation for axatilimab in chronic lung disease,4/8/2021 8:49:19 PM
SNDX,Syndax Pharmaceuticals files for $75M mixed shelf offering,3/22/2021 8:39:03 PM
SNDX,Syndax Pharmaceuticals reports Q4 results,3/8/2021 9:12:29 PM
SNDX,The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings,3/6/2021 4:57:58 PM
SNDX,Citius Pharmaceuticals Is Addressing Several Unmet Needs In The Medical Field,2/4/2021 4:16:13 PM
SNDX,Syndax prices equity offering at $23,12/9/2020 11:53:16 AM
SNDX,Syndax Pharmaceutical readies proposed public offering,12/7/2020 9:47:38 PM
SNDX,Kura Oncology down 15% on KO-539 safety signals in early-stage study,11/4/2020 2:04:34 PM
SNDX,Here's what Wall Street expects from Syndax Pharmaceuticals's earnings report,11/1/2020 3:01:30 PM
SNDX,Syndax Pharmaceuticals is about to announce earnings — here's what Wall Street expects,8/5/2020 3:04:13 PM
SNDX,"ZYNE, CLSN, SNCA and SNDX among midday movers",5/22/2020 4:40:46 PM
SNDX,"HPE, TLRY, PANW and RENN among after-hours movers",5/21/2020 9:47:08 PM
SNDX,Syndax Pharmaceuticals is about to announce its earnings — here's what Wall Street expects,5/7/2020 3:02:03 PM
SNDX,Syndax prices stock offering at $18; shares ahead 3% premarket,4/30/2020 12:02:26 PM
SNDX,"Do You Have These Stocks In Your Portfolio? (SNDX, ERYP, IMRA...) ",4/29/2020 12:08:05 PM
SNDX,"NGL, GLOG, OXSQ and CINF among midday movers",4/28/2020 4:42:21 PM
SNDX,Syndax +21.6% after early leukemia-drug data,4/27/2020 10:37:47 PM
SNDX,Will 2020 Be An Exciting And Transformative Year For Syndax Pharma (SNDX)? ,3/6/2020 11:03:21 AM
SNDX,"OCUL, AIM, INFN and OMI among midday movers",3/4/2020 5:39:09 PM
SNDX,Here's what Wall Street expects from Syndax Pharmaceuticals's earnings report,3/2/2020 3:01:32 PM
SNDX,"Top 5 Losers In Healthcare Sector (NXTC, SNDX, COCP…) ",10/10/2019 7:04:46 AM
SNDX,Here's what Wall Street expects from Syndax Pharmaceuticals's earnings,8/5/2019 3:03:10 PM
SNDX,7 Stocks to Buy With Over 20% Upside From Current Levels,7/30/2019 10:11:00 AM
SNDX,Biopulse: 5 Stocks Under $10 Worth Watching ,6/28/2019 12:30:19 PM
SNDX,What Wall Street expects from Syndax Pharmaceuticals's earnings,5/4/2019 3:01:24 PM
SNDX,"6 Top Gainers In Healthcare Sector (IMAC, SNDX, WCG...) ",3/28/2019 4:13:54 AM
SNDX,Syndax Pharmaceuticals earnings preview: what to expect,3/5/2019 3:01:34 PM
SNDX,Syndax Pharmaceuticals is about to announce its earnings — here's what Wall Street expects,11/3/2018 3:01:32 PM
SNDX,"FDA Nod For VSTM, ANAB Breathes Easy, GEMP Trims Workforce By 33% ",9/25/2018 7:08:19 AM
SNDX,"Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) ",9/22/2018 10:07:24 AM
SNDX,"Week Ahead In Pharmaceuticals: 7 Stocks To Watch (CMRX, VRNA, NITE...) ",9/15/2018 2:48:58 AM
SNDX,Syndax Pharmaceuticals earnings: here's what Wall Street expects,8/5/2018 3:01:59 PM
SNDX,"CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov. ",5/31/2018 6:55:51 AM
SNDX,Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration,5/30/2018 10:05:00 PM
SNDX,Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab),5/17/2018 1:00:00 PM
SNDX,BRIEF-Syndax Pharmaceuticals Reports Q1 Loss Per Share $0.79,5/8/2018 10:38:20 PM
SNDX,"Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018",5/1/2018 1:00:00 PM
SNDX,Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting,4/25/2018 10:05:00 PM
SNDX,Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting,4/13/2018 1:00:00 PM
SNDX,"DXR Soars On Big Volume, RXII Gets Attention, Busy Q2 Awaits SNDX ",3/15/2018 2:02:28 AM
SNDX,Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update,3/5/2018 10:05:00 PM
SNDX,"Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018",2/26/2018 1:00:00 PM
SNDX,Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting,2/22/2018 1:00:00 PM
SNDX,Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca,2/1/2018 1:00:00 PM
SNDX,Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer,1/10/2018 1:00:00 PM
SNDX,"NKTR's Pivot Data Pleases Investors, OPHT Catches Eyes, CALA Craters, Wave Rises ",11/14/2017 4:31:18 AM
SNDX,Syndax Pharmaceuticals Announces Presentation of Data from Immuno-oncology Clinical Trials at the Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting,11/11/2017 9:00:00 PM
SNDX,Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update,11/7/2017 10:05:00 PM
SNDX,"Syndax to Announce Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7, 2017",10/31/2017 12:00:00 PM
SNDX,Syndax Expands Pipeline with Exclusive Worldwide License to Allergan's Portfolio of Menin-MLL Inhibitors,10/17/2017 1:00:00 PM
SNDX,Syndax Announces Dosing of First Patient in Pivotal Trial of Entinostat for the Treatment of Advanced or Recurrent Breast Cancer in Japan by Partner Kyowa Hakko Kirin,10/5/2017 1:00:00 PM
SNDX,Syndax Pharmaceuticals Announces Updated Presentation Time at the Cantor Fitzgerald Global Healthcare Conference,9/20/2017 1:00:00 PM
SNDX,Syndax Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences,8/30/2017 1:00:00 PM
SNDX,Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update,8/10/2017 10:05:00 PM
SNDX,"Syndax to Announce Second Quarter 2017 Financial Results and Host Conference Call and Webcast on August 10, 2017",8/3/2017 1:00:00 PM
SNDX,"Gainers & Losers Of May 25: AERI, BCRX, NEOT, SNDX, SYRS... ",5/26/2017 2:43:07 AM
SNDX,"MRK's Keytruda Scores Another FDA Nod, NBIX Disappoints, SBPH Achieves It ",5/24/2017 7:25:21 AM
SNDX,"SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall ",5/18/2017 8:22:28 AM
